Evidence map›Paper›PMID 42793938›Full record

ArticleEntropy (Basel, Switzerland)2026

Detecting Unseen IoT Attacks with Calibrated Dual Evidence Under Low False-Positive Budget.

Jiahui Yue, Yuliang Lu, Yi Xie

Abstract read
In one paragraph

Article in Entropy (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jiahui YueCollege of Electronic Engineering, National University of Defense Technology, Hefei 230037, China.ORCID 0000-0002-6404-9933
Yuliang LuCollege of Electronic Engineering, National University of Defense Technology, Hefei 230037, China.ORCID 0000-0002-8502-9907
Yi XieCollege of Electronic Engineering, National University of Defense Technology, Hefei 230037, China.ORCID 0000-0001-7539-919X

Funding

National Natural Science Foundation of China 62502529
6 · The paper itself

Abstract

Internet of Things (IoT) traffic anomaly detection is essential for limiting device compromise and large-scale attacks. Existing detectors may miss attack families absent from model development, while heterogeneous benign traffic makes it difficult to maintain a low false-positive rate (FPR). To address these two practical limitations, we propose the Mode-Calibrated Dual-Evidence Detector (MCDE). Its supervised branch estimates the probability that a sample is malicious from labeled benign and known-attack traffic, while its benign-deviation branch measures distance from multiple learned benign traffic modes, providing a complementary route for unseen attacks. MCDE maps the heterogeneous probability and distance scores to comparable empirical benign-tail evidence, normalizes each branch by its allocated share of the target FPR, and fuses them into an anomaly score. A disjoint held-out benign set determines the decision threshold. Equivalently, the fusion compares budget-adjusted benign-tail surprisal, linking the decision rule to empirical self-information. We further establish the conditions under which the budgeted fusion controls the nominal overall FPR. Family-hold-out experiments on IoT-23 and N-BaIoT validate MCDE. At a 1% target benign FPR, MCDE improves IoT-23 unseen recall over histogram-based gradient boosting from 85.77% to 90.85% and harmonic known-unseen recall from 91.82% to 95.07%, while maintaining a 0.96% benign-test FPR. It also achieves 99.87% unseen recall on N-BaIoT.

Indexed as

benign-tail surprisalempirical score calibrationfalse-positive rate controlInternet of Thingsnetwork traffic anomaly detectionunseen-attack detection

Identifiers

PMID42793938
PMCPMC13605448

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.